Goldman Sachs Group Inc Morphic Holding, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$26.12 - $34.07 $2.34 Million - $3.05 Million	89,628 Added 16.48%	633,573 $21.6 Million
Q1 2024 May 15, 2024	SELL	$26.64 - $40.31 $2.43 Million - $3.67 Million	-91,119 Reduced 14.35%	543,945 $19.1 Million
Q4 2023 Feb 13, 2024	BUY	$19.95 - $31.0 $5.94 Million - $9.22 Million	297,567 Added 88.17%	635,064 $18.3 Million
Q3 2023 May 14, 2024	SELL	$21.33 - $59.42 $6.35 Million - $17.7 Million	-297,567 Reduced 46.86%	337,497 $7.73 Million
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $392,599 - $1.09 Million	-18,406 Reduced 5.17%	337,497 $7.73 Million
Q2 2023 May 14, 2024	BUY	$34.33 - $62.11 $4.23 Million - $7.66 Million	123,314 Added 53.02%	355,903 $20.4 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $4.23 Million - $7.66 Million	123,314 Added 53.02%	355,903 $20.4 Million
Q1 2023 May 14, 2024	BUY	$26.01 - $48.69 $978,574 - $1.83 Million	37,623 Added 19.3%	232,589 $8.75 Million
Q1 2023 May 11, 2023	BUY	$26.01 - $48.69 $978,574 - $1.83 Million	37,623 Added 19.3%	232,589 $8.75 Million
Q4 2022 May 14, 2024	BUY	$24.14 - $30.37 $1.84 Million - $2.31 Million	76,129 Added 64.06%	194,966 $5.22 Million
Q4 2022 Feb 13, 2023	BUY	$24.14 - $30.37 $1.84 Million - $2.31 Million	76,129 Added 64.06%	194,966 $5.22 Million
Q3 2022 May 14, 2024	SELL	$22.23 - $33.37 $398,139 - $597,656	-17,910 Reduced 13.1%	118,837 $3.36 Million
Q3 2022 Nov 10, 2022	SELL	$22.23 - $33.37 $398,139 - $597,656	-17,910 Reduced 13.1%	118,837 $3.36 Million
Q2 2022 May 14, 2024	SELL	$19.74 - $43.01 $9.84 Million - $21.4 Million	-498,317 Reduced 78.47%	136,747 $2.97 Million
Q2 2022 Aug 15, 2022	SELL	$19.74 - $43.01 $417,658 - $910,005	-21,158 Reduced 13.4%	136,747 $2.97 Million
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $840,130 - $1.21 Million	-23,176 Reduced 12.8%	157,905 $6.34 Million
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $420,627 - $638,864	9,721 Added 5.67%	181,081 $8.58 Million
Q3 2021 Nov 10, 2021	BUY	$53.61 - $67.5 $9.19 Million - $11.6 Million	171,360 New	171,360 $9.71 Million

Others Institutions Holding MORF

# of Institutions

Shares Held

4.7M

Call Options Held

Put Options Held

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account